MIM
ACET icon

Monashee Investment Management’s Adicet Bio ACET Stock Holding History

Monashee Investment Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,339
Closed -$1.02M – 160
2019
Q1 		$1.02M Buy
+1,339
New +$1.22M 0.24% 93

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Monashee Investment Management's ACET Position: Q2 2019 in Review

Monashee Investment Management sold out of Adicet Bio (ACET) in Q2 2019, closing a stake of 1,339 shares — an estimated $1.02M sold.

Monashee Investment Management first reported a position in ACET in Q1 2019 and held it in 1 quarter. The position peaked at $1.02M in Q1 2019. 48 funds tracked by Wall St. Rank hold ACET as of Q2 2019.

  • Monashee Investment Management reported no remaining Adicet Bio position as of Q2 2019 after selling out during the quarter.
  • Monashee Investment Management sold 1,339 Adicet Bio shares in Q2 2019, an estimated $1.02M.
  • Monashee Investment Management first reported a position in Adicet Bio in Q1 2019 and held it in 1 quarter.
  • Monashee Investment Management's Adicet Bio position peaked at $1.02M in Q1 2019.
  • 48 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2019.

Based on Monashee Investment Management's 13F filing for Q2 2019, filed 7 Aug 2019.